However, patients prescribed tirzepatide often have underlying conditionssuch as diabetes and obesitythat independently elevate cardiovascular risk
Important safety considerations include a boxed warning for thyroid C-cell tumors, contraindications in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and risks of pancreatitis, gallbladder disease, hypoglycemia (when used with insulin or insulin secretagogues), and acute kidney injury
Additionally, a qualification study is required to assess potential immunogenicity risks
Parlez un conseiller en soins aux patients c'est gratuit, confidentiel et disponible 24h/24 et 7j/7
Accountability through regular weigh-ins, whether self-directed or professionally supervised, helps maintain focus and allows early intervention when weight trends upward
Nature of cerebral functional defects and their effect on fitness to drive
